AU4829593A - Inhalation device - Google Patents

Inhalation device

Info

Publication number
AU4829593A
AU4829593A AU48295/93A AU4829593A AU4829593A AU 4829593 A AU4829593 A AU 4829593A AU 48295/93 A AU48295/93 A AU 48295/93A AU 4829593 A AU4829593 A AU 4829593A AU 4829593 A AU4829593 A AU 4829593A
Authority
AU
Australia
Prior art keywords
inhalation device
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48295/93A
Inventor
Alastair Robert Clarke
Bruce James Renfrew
Michael Trevor Shepherd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929220077A external-priority patent/GB9220077D0/en
Priority claimed from GB929220083A external-priority patent/GB9220083D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of AU4829593A publication Critical patent/AU4829593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/14—Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU48295/93A 1992-09-23 1993-09-23 Inhalation device Abandoned AU4829593A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB929220077A GB9220077D0 (en) 1992-09-23 1992-09-23 Inhalation device
GB9220083 1992-09-23
GB929220083A GB9220083D0 (en) 1992-09-23 1992-09-23 Inhalation device
GB9220077 1992-09-23
PCT/GB1993/002013 WO1994006498A1 (en) 1992-09-23 1993-09-23 Inhalation device

Publications (1)

Publication Number Publication Date
AU4829593A true AU4829593A (en) 1994-04-12

Family

ID=26301671

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48295/93A Abandoned AU4829593A (en) 1992-09-23 1993-09-23 Inhalation device

Country Status (2)

Country Link
AU (1) AU4829593A (en)
WO (1) WO1994006498A1 (en)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492112A (en) * 1991-05-20 1996-02-20 Dura Pharmaceuticals, Inc. Dry powder inhaler
DE4318455A1 (en) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Capsule holder
NZ293163A (en) * 1994-09-21 1998-09-24 Inhale Therapeutic Syst Inhalation medicament disperser, aerosol from high pressure gas entrainment of fluidised powder drawn from receptacle feed tube
JP3317823B2 (en) * 1995-08-11 2002-08-26 株式会社ユニシアジェックス Dosing device
JP3328132B2 (en) * 1996-03-21 2002-09-24 株式会社ユニシアジェックス Inhaler type dispenser
US5794613A (en) * 1997-01-09 1998-08-18 Sepracor, Inc. Multiple-dose dispenser for dry powder inhalers
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
US20010029947A1 (en) 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US7288390B2 (en) 2000-08-07 2007-10-30 Centocor, Inc. Anti-dual integrin antibodies, compositions, methods and uses
US6902734B2 (en) 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
UA81743C2 (en) 2000-08-07 2008-02-11 Центокор, Инк. HUMAN MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS TUMOR NECROSIS FACTOR ALFA (TNFα), PHARMACEUTICAL MIXTURE CONTAINING THEREOF, AND METHOD FOR TREATING ARTHRITIS
SE517227C2 (en) * 2000-09-25 2002-05-14 Microdrug Ag Dry powder inhaler with foil cutter
DE10128779A1 (en) † 2001-06-13 2003-01-02 Boehringer Ingelheim Pharma Process for cleaning hard gelatin capsules
PT2308888T (en) 2001-11-14 2017-05-03 Janssen Biotech Inc Anti-il-6 antibodies, compositions, methods and uses
ATE421249T1 (en) 2002-02-13 2009-02-15 Immunology Lab Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF MICROORGANISM INFECTIONS
CA2490409A1 (en) 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
UA89481C2 (en) 2003-09-30 2010-02-10 Центокор, Инк. Human epo mimetic hinge core mimetibodies, compositions, methods and uses
WO2005040163A1 (en) 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
DE10352277A1 (en) 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
US20070135338A1 (en) 2004-03-31 2007-06-14 Karyn O'neil Human GLP-1 mimetibodies, compositions, methods and uses
JO3058B1 (en) 2005-04-29 2017-03-15 Applied Molecular Evolution Inc Anti-IL-6 Antibodies,Compositions,Methods and uses
SI2452694T1 (en) 2005-06-30 2019-05-31 Janssen Biotech, Inc. Anti-IL-23 antibodies, compositions, methods and uses
HUE034269T2 (en) 2005-12-29 2018-02-28 Janssen Biotech Inc Human anti-il-23 antibodies, compositions, methods and uses
DE102006016904A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
DE102006016901A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mouthpiece for an inhaler
DE102006017699A1 (en) 2006-04-15 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
HUE048024T2 (en) 2006-08-10 2020-05-28 Roy C Levitt Anakinra for use in the treatment of bronchiolitis obliterans syndrome
AR064623A1 (en) 2006-12-21 2009-04-15 Centocor Inc USE OF LONG-TERM GLP-1 RECEPTOR AGONISTS TO IMPROVE INSULIN SENSITIVITY AND LIPID PROFILES
TR200803524A2 (en) * 2008-05-16 2009-12-21 Bi̇lgi̇ç Mahmut Inhalation device.
KR20160116056A (en) 2008-08-14 2016-10-06 테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디 Anti-il-12/il-23 antibodies
ES2705714T3 (en) 2008-10-31 2019-03-26 Janssen Biotech Inc Methods and uses of domain of Fibronectina type III based on structures of compositions
BRPI1008532B1 (en) 2009-02-12 2021-12-14 Janssen Biotech, Inc ISOLATED PROTEIN FRAMEWORK, METHOD FOR BUILDING AN ISOLATED PROTEIN FRAMEWORK LIBRARY, ISOLATED NUCLEIC ACID MOLECULE, ISOLATED NUCLEIC ACID VECTOR, BACTERIAL OR FUNGUS HOST CELL, COMPOSITION, MEDICAL DEVICE AND MANUFACTURING ARTICLE FOR PRODUCT USE IN HUMAN BEINGS
CN103800906B (en) 2009-03-25 2017-09-22 德克萨斯大学系统董事会 For stimulating mammal to the composition of the congenital immunity resistance of pathogen
KR20130009760A (en) 2010-02-10 2013-01-23 이뮤노젠 아이엔씨 Cd20 antibodies and uses thereof
EP3323830B1 (en) 2010-06-19 2023-08-23 Memorial Sloan-Kettering Cancer Center Anti-gd2 antibodies
WO2012175735A1 (en) 2011-06-23 2012-12-27 Vib Vzw A20 inhibitors for the treatment of respiratory viral infections
TW201427681A (en) 2013-01-07 2014-07-16 Superlab Far East Ltd A method for treating tumor by using recombinant interferon with changed spatial configuration
ES2805316T3 (en) * 2013-03-08 2021-02-11 Interquim Sa Inhaler
RU2680267C2 (en) 2013-03-15 2019-02-19 Мемориал Слоан Кеттеринг Кэнсер Сентер High-affinity anti-gd2 antibodies
WO2018140026A1 (en) 2017-01-27 2018-08-02 Memorial Sloan Kettering Cancer Center Bispecific her2 and cd3 binding molecules
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
SG11201707538XA (en) 2015-03-17 2017-10-30 Memorial Sloan Kettering Cancer Center Anti-muc16 antibodies and uses thereof
PL3138600T3 (en) * 2015-09-04 2020-04-30 Victor Esteve Dry powder inhaler
WO2018014039A1 (en) 2016-07-15 2018-01-18 Poseida Therapeutics, Inc. Chimeric antigen receptors (cars) specific for muc1 and methods for their use
RU2019104074A (en) 2016-07-15 2020-08-18 Посейда Терапьютикс, Инк. CHIMERIC ANTIGEN RECEPTORS AND METHODS OF THEIR APPLICATION
US11826422B2 (en) 2016-11-09 2023-11-28 Board Of Regents, The University Of Texas System Methods and compositions for adaptive immune modulation
CA3047098A1 (en) 2016-12-16 2018-06-21 Jia Zhou Inhibitors of bromodomain-containing protein 4 (brd4)
BR112019012727B1 (en) * 2016-12-20 2022-11-16 Emphasys Importadora Exportadora E Distribuidora Ltda DRY POWDER INHALER
WO2018140121A1 (en) 2017-01-30 2018-08-02 Janssen Biotech, Inc. Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
MX2019009377A (en) 2017-02-07 2019-12-11 Janssen Biotech Inc ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS.
US12415844B2 (en) 2017-12-20 2025-09-16 Poseida Therapeutics, Inc. BCMA specific VCAR compositions and methods for use
AU2019215202B2 (en) 2018-02-01 2025-11-13 Memorial Sloan Kettering Cancer Center Antibodies to Galectin-3 and methods of use thereof
US20190345245A1 (en) 2018-05-11 2019-11-14 Janssen Biotech, Inc. Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
US11389433B2 (en) 2018-06-18 2022-07-19 Board Of Regents, The University Of Texas System BRD4 inhibitor treatment of IgE-mediated diseases
JP7689074B2 (en) 2019-01-15 2025-06-05 ヤンセン バイオテツク，インコーポレーテツド Anti-TNF antibodies, compositions, and methods for the treatment of juvenile idiopathic arthritis
WO2020152544A1 (en) 2019-01-23 2020-07-30 Janssen Biotech, Inc. Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
EA202192505A1 (en) 2019-03-14 2022-03-29 Янссен Байотек, Инк. METHODS FOR OBTAINING COMPOSITIONS OF ANTIBODIES TO TNF
WO2020183269A1 (en) 2019-03-14 2020-09-17 Janssen Biotech, Inc. Manufacturing methods for producing anti-tnf antibody compositions
KR20210141998A (en) 2019-03-14 2021-11-23 얀센 바이오테크 인코포레이티드 Method of making anti-TNF antibody composition
JP7805788B2 (en) 2019-05-23 2026-01-26 ヤンセン バイオテツク，インコーポレーテツド Method for treating inflammatory bowel disease with combined therapy of antibodies against IL-23 and TNF alpha
MX2021014882A (en) 2019-06-03 2022-03-25 Janssen Biotech Inc ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDILITIS.
JP2022536279A (en) 2019-06-03 2022-08-15 ヤンセン バイオテツク，インコーポレーテツド Anti-TNF antibody compositions and methods for treating psoriatic arthritis
WO2020257845A1 (en) * 2019-06-24 2020-12-30 De Motu Cordis Pty Ltd Automatic dispenser for respiratory delivery device
US11717621B2 (en) 2019-06-24 2023-08-08 De Motu Cordis Pty Ltd Automatic dispenser for respiratory delivery device
WO2021028752A1 (en) 2019-08-15 2021-02-18 Janssen Biotech, Inc. Anti-tfn antibodies for treating type i diabetes
WO2021211628A1 (en) 2020-04-14 2021-10-21 Poseida Therapeutics, Inc. Compositions and methods for use in the treatment of cancer
WO2021214587A1 (en) 2020-04-21 2021-10-28 Janssen Biotech, Inc. Anti-tnf alpha agent for treating viral infections
WO2021214588A1 (en) 2020-04-21 2021-10-28 Janssen Biotech, Inc. Anti-tnf alpha agent for treating coronavirus infections
IL298389A (en) 2020-05-21 2023-01-01 Janssen Biotech Inc A method for the treatment of inflammatory bowel diseases with a combined treatment of antibodies to il-23 and TNF alpha
MX2023001366A (en) 2020-07-31 2023-04-26 Pinetree Therapeutics Inc Neuropilin and angiotensin converting enzyme 2 fusion peptides for treating viral infections.
WO2023279115A1 (en) 2021-07-02 2023-01-05 Henry Ford Health System Compositions comprising endosidin 2 for reducing sars-cov-2 infection
US12534524B2 (en) 2021-07-09 2026-01-27 Janssen Biotech, Inc. Manufacturing methods for producing anti-TNF antibody compositions
EP4367136A1 (en) 2021-07-09 2024-05-15 Janssen Biotech, Inc. Manufacturing methods for producing anti-tnf antibody compositions
EP4719547A1 (en) * 2023-06-02 2026-04-08 Alfred Von Schuckmann An inhaler for powdered substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1566604C3 (en) * 1966-09-17 1980-10-23 Fisons Pharmaceuticals Ltd., Loughborough, Leicestershire (Ver. Koenigreich) Device for the oral inhalation of medication in finely divided form
GB1268051A (en) * 1968-06-07 1972-03-22 Fisons Pharmaceuticals Ltd Inhalation device
GB1598081A (en) * 1977-02-10 1981-09-16 Allen & Hanburys Ltd Inhaler device for dispensing medicaments

Also Published As

Publication number Publication date
WO1994006498A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
AU4829593A (en) Inhalation device
AU7202591A (en) Inhalation device
AU8220991A (en) Inhalation device
AU7089591A (en) Inhalation device
GB9217545D0 (en) Inhalation device
AU119600S (en) Inhaler device
AU5189893A (en) Catheter device
AU7102596A (en) Inhalation device
AU4544593A (en) Flipover carrying device
AU121578S (en) An inhalation device
AU1444092A (en) Drop-producing device
AU4295993A (en) Inhalation device
AU4348493A (en) Inhaler
AU4125793A (en) Medico-surgical devices
AU7227494A (en) Inhalator
AU3258793A (en) Foam-spraying device
AU5171893A (en) Theft-detection device
AU4591193A (en) Hand held device
AU4949093A (en) Tinnitus-treatment device
AU687103C (en) Device for inhalation
CA71018S (en) Inhalation device
CA71017S (en) Inhalation device
CA73544S (en) Inhalation device
GB9223413D0 (en) Inhalation device
GB9220077D0 (en) Inhalation device